147 related articles for article (PubMed ID: 37678990)
1. The role of sialylation in gynecologic cancers.
Yang ST; Liu CH; Chao WT; Liu HH; Lee WL; Wang PH
Taiwan J Obstet Gynecol; 2023 Sep; 62(5):651-654. PubMed ID: 37678990
[TBL] [Abstract][Full Text] [Related]
2. Sialylation: an Avenue to Target Cancer Cells.
Vajaria BN; Patel KR; Begum R; Patel PS
Pathol Oncol Res; 2016 Jul; 22(3):443-7. PubMed ID: 26685886
[TBL] [Abstract][Full Text] [Related]
3. Aberrant sialylation in ovarian cancers.
Lee WL; Wang PH
J Chin Med Assoc; 2020 Apr; 83(4):337-344. PubMed ID: 31904658
[TBL] [Abstract][Full Text] [Related]
4. The role of sialyltransferases in gynecological malignant tumors.
Zhang Y; Wang R; Feng Y; Ma F
Life Sci; 2020 Dec; 263():118670. PubMed ID: 33121992
[TBL] [Abstract][Full Text] [Related]
5. A new histobiochemical method to analyze sialylation on cell-surface glycoproteins of head and neck squamous-cell carcinomas.
Bergler W; Riedel F; Schwartz-Albiez R; Gross HJ; Hörmann K
Eur Arch Otorhinolaryngol; 1997; 254(9-10):437-41. PubMed ID: 9438113
[TBL] [Abstract][Full Text] [Related]
6. Sialic acids in gynecological cancer development and progression: Impact on diagnosis and treatment.
Berghuis AY; Pijnenborg JFA; Boltje TJ; Pijnenborg JMA
Int J Cancer; 2022 Feb; 150(4):678-687. PubMed ID: 34741527
[TBL] [Abstract][Full Text] [Related]
7. Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma.
Ho WL; Hsu WM; Huang MC; Kadomatsu K; Nakagawara A
J Hematol Oncol; 2016 Sep; 9(1):100. PubMed ID: 27686492
[TBL] [Abstract][Full Text] [Related]
8. Abnormal sialylation and fucosylation of saliva glycoproteins: Characteristics of lung cancer-specific biomarkers.
Gao Z; Xu M; Yue S; Shan H; Xia J; Jiang J; Yang S
Curr Res Pharmacol Drug Discov; 2022; 3():100079. PubMed ID: 35005612
[TBL] [Abstract][Full Text] [Related]
9. Distinct patterns of plaque and microglia glycosylation in Alzheimer's disease.
Fastenau C; Bunce M; Keating M; Wickline J; Hopp SC; Bieniek KF
Brain Pathol; 2024 May; ():e13267. PubMed ID: 38724175
[TBL] [Abstract][Full Text] [Related]
10. ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.
Scott E; Archer Goode E; Garnham R; Hodgson K; Orozco-Moreno M; Turner H; Livermore K; Putri Nangkana K; Frame FM; Bermudez A; Jose Garcia Marques F; McClurg UL; Wilson L; Thomas H; Buskin A; Hepburn A; Duxfield A; Bastian K; Pye H; Arredondo HM; Hysenaj G; Heavey S; Stopka-Farooqui U; Haider A; Freeman A; Singh S; Johnston EW; Punwani S; Knight B; McCullagh P; McGrath J; Crundwell M; Harries L; Heer R; Maitland NJ; Whitaker H; Pitteri S; Troyer DA; Wang N; Elliott DJ; Drake RR; Munkley J
J Pathol; 2023 Sep; 261(1):71-84. PubMed ID: 37550801
[TBL] [Abstract][Full Text] [Related]
11. Aberrant sialylation and fucosylation of intracellular proteins in cervical tissue are critical markers of cervical carcinogenesis.
Kim HJ; Kim SC; Ju W; Kim YH; Yin SY; Kim HJ
Oncol Rep; 2014 Mar; 31(3):1417-22. PubMed ID: 24366620
[TBL] [Abstract][Full Text] [Related]
12. ST6Gal-I sialyltransferase promotes tumor necrosis factor (TNF)-mediated cancer cell survival via sialylation of the TNF receptor 1 (TNFR1) death receptor.
Holdbrooks AT; Britain CM; Bellis SL
J Biol Chem; 2018 Feb; 293(5):1610-1622. PubMed ID: 29233887
[TBL] [Abstract][Full Text] [Related]
13. Disruption of sialic acid metabolism drives tumor growth by augmenting CD8
Cornelissen LAM; Blanas A; van der Horst JC; Kruijssen L; Zaal A; O'Toole T; Wiercx L; van Kooyk Y; van Vliet SJ
Int J Cancer; 2019 May; 144(9):2290-2302. PubMed ID: 30578646
[TBL] [Abstract][Full Text] [Related]
14. ST6GAL1: A key player in cancer.
Garnham R; Scott E; Livermore KE; Munkley J
Oncol Lett; 2019 Aug; 18(2):983-989. PubMed ID: 31423157
[TBL] [Abstract][Full Text] [Related]
15. Sialylation regulates myofibroblast differentiation of human skin fibroblasts.
Sasaki N; Itakura Y; Toyoda M
Stem Cell Res Ther; 2017 Apr; 8(1):81. PubMed ID: 28420408
[TBL] [Abstract][Full Text] [Related]
16. Aberrant Sialylation in Cancer: Therapeutic Opportunities.
Munkley J
Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077781
[TBL] [Abstract][Full Text] [Related]
17. α2,6-Sialylation promotes immune escape in hepatocarcinoma cells by regulating T cell functions and CD147/MMP signaling.
Wang L; Li S; Yu X; Han Y; Wu Y; Wang S; Chen X; Zhang J; Wang S
J Physiol Biochem; 2019 Jun; 75(2):199-207. PubMed ID: 30972697
[TBL] [Abstract][Full Text] [Related]
18. Glycoengineering of therapeutic glycoproteins: in vitro galactosylation and sialylation of glycoproteins with terminal N-acetylglucosamine and galactose residues.
Raju TS; Briggs JB; Chamow SM; Winkler ME; Jones AJ
Biochemistry; 2001 Jul; 40(30):8868-76. PubMed ID: 11467948
[TBL] [Abstract][Full Text] [Related]
19. An integrated modular framework for modeling the effect of ammonium on the sialylation process of monoclonal antibodies produced by CHO cells.
Savizi ISP; Motamedian E; E Lewis N; Jimenez Del Val I; Shojaosadati SA
Biotechnol J; 2021 Aug; 16(8):e2100019. PubMed ID: 34021707
[TBL] [Abstract][Full Text] [Related]
20. Reduced α-2,6 sialylation regulates cell migration in endometriosis.
Maignien C; Santulli P; Chouzenoux S; Gonzalez-Foruria I; Marcellin L; Doridot L; Jeljeli M; Grange P; Reis FM; Chapron C; Batteux F
Hum Reprod; 2019 Mar; 34(3):479-490. PubMed ID: 30753458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
